22157.jpg
Benign Prostatic Hypertrophy Drug Market Projections: Industry Growth Forecast to 2028
February 12, 2024 04:28 ET | Research and Markets
Dublin, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The "Drugs For Benign Prostatic hypertrophy Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Benign Prostatic...
Global Pulmonary Arterial Hypertension (PAH) Drugs Market
Insights on the Pulmonary Arterial Hypertension (PAH) Drugs Global Market to 2027: Increasing Prevalence of Cardiovascular and Pulmonary Disorders Drives Growth
February 03, 2023 04:58 ET | Research and Markets
Dublin, Feb. 03, 2023 (GLOBE NEWSWIRE) -- The "Pulmonary Arterial Hypertension (PAH) Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been...
FCL.png
Luigi Franciosi to Advise on New Asthma & COPD Drug Development Programs for Vicenna Pharmaceuticals Inc.
January 07, 2020 12:30 ET | Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Franciosi Consulting Ltd. (“FCL”) is pleased to announce that its President and CEO, Dr. Luigi Franciosi, has been retained as a...
logo long.jpg
Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market to Surpass US$ 21.8 Billion by 2026
May 28, 2019 08:30 ET | CMI
SEATTLE, May 28, 2019 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global chronic obstructive pulmonary disease (COPD) treatment market was valued at US$ 14,209.0 million in 2017 and...